Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qutenza in Obese Patients with Knee Osteoarthritis
NCT03153813Phase 3Terminated
- Start
- Jul 2015
- Primary completion
- Dec 2017
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of capsaicin in osteoarthritis (OA) (2 arms). Primary endpoint: Numerical Rating Scale Pain Intensity at 3 months. Started Jul 2015; status: terminated.
02
Drugs
capsaicin
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT03153813.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03153813.